Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single‐centre experience

AIMS: Heart failure with reduced ejection fraction (HFrEF) is associated with excessive sympathetic and impaired parasympathetic activity. The Barostim Neo™ device is used for electronical baroreflex activation therapy (BAT) to counteract autonomic nervous system dysbalance. Randomized trials have s...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanco, Carola, Madej, Tomas, Mangner, Norman, Hommel, Jennifer, Grimm, Susanna, Knaut, Michael, Linke, Axel, Winzer, Ephraim B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682889/
https://www.ncbi.nlm.nih.gov/pubmed/37667319
http://dx.doi.org/10.1002/ehf2.14508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682889/
https://www.ncbi.nlm.nih.gov/pubmed/37667319
http://dx.doi.org/10.1002/ehf2.14508

Ejemplares similares